Brar, J. S., Maise, A. A., Bruce, D. J., Bills, L. J., Fertall, L. A. and Schuster, J. (2025). Value Based Purchasing to Increase Tobacco Cessation Counseling and Medications in Behavioral Health Homes. Community Ment Health J. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41261307
Jones, L., Elliott, M., Price, K. M., Baillie, J. and Hewitt, R. (2025). Challenges of recruiting nurses as participants in research studies: insights from a smoking cessation study. Nurse Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41306109
Sun, H., Chen, J., Wu, X. and Wang, Z. (2025). Sex-stratified pharmacovigilance of gastrointestinal events associated with first-line smoking-cessation medicines: Insights from the FAERS database. PLoS One, 11, e0336021. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41196915
Tam, A., Munsar, Z. and Opler, D. J. (2025). Reconsidering Ondansetron for Smoking Cessation: A Call for Renewed Investigation. Pharmacol Res Perspect, 6, e70195. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41243401
Zhou, X., Huang, Z., Song, Q., Xia, X., Cheng, A., Liu, Z., Wang, M., Ji, T., Aihemaiti, A., Xie, Y., Liu, Y., Shi, Y., Shi, S., Gao, Y., Liu, H., He, J., Zhao, L., Xiao, D. and Wang, C. (2025). Efficacy of combined varenicline and nicotine replacement therapy compared with varenicline or nicotine replacement therapy alone for smoking cessation: A systematic review and meta-analysis. Addiction. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41208435
Bailey, S. R., Hwang, J., Lucas, J. A., Lyon-Scott, K., Marino, M., Datta, R., Quinones, A. R., Chan, B. and Heintzman, J. (2025). Tobacco Use Assessment and Cessation Medication Orders Among Primary Care Patients by Ethnicity, Sex, and Acculturation Indicators. J Gen Intern Med. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41032200
Braun, A., Hyll, W. and Krczal, E. (2025). Breaking the habit: a systematic review of the cost-effectiveness of non-pharmacological and combined interventions for smoking cessation in Europe. Eur J Health Econ. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41160307
De Santi, O., Di Niro, C. A., Rungruanghiranya, S. and Greco, V. (2025). Evaluation of the effectiveness of Vernonia cinerea for the treatment of smoking cessation: a systematic review and meta-analysis. J Ethnopharmacol, Pt B, 120690. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41076145
Halliday, D. M., Schneider, S., Wakefield, T., Durazo, A., Tracy, D., Song, A. V. and Apollonio, D. E. (2025). An Observational Study of Nicotine Replacement Therapy Availability Through Pharmacist Prescribing in the California Central Valley. Tob Use Insights, 1179173X251387417. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41122490
Tashkin, D. P. and Melamed, K. H. (2025). Comparative efficacy in smokers with versus without COPD: a new addition of an old drug to approved pharmacotherapy for smoking cessation. Thorax. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41167618
Kim, S., Carlson, B., Chen, K. and Sabatelli, F. (2025). Recurrent pulmonary embolism and azygos vein thrombosis during varenicline therapy for smoking cessation. Oxf Med Case Reports, 9, omaf164. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41025020
King, D. and University, A. C. P. J. C. E. T. a. M. (2025). Cytisinicline for 6 or 12 wk increased smoking cessation rates after treatment and up to 24 wk. Ann Intern Med, 9, JC105. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40889365
Minian, N., Mehra, K., Rose, J., Veldhuizen, S., Zawertailo, L., Ratto, M., Ting, A. K. R., Melamed, O., Tang, V. and Selby, P. (2025). Using the behaviour change wheel framework to develop a rule-based chatbot to support varenicline adherence for smoking cessation. Digit Health, 2.05521E+16. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40995424
Mir, H., Mullen, K. A., Heshmati, J., Baldwin, A., Quirouette, E., Serano, E., Coja, M., Pipe, A. L. and Reid, R. D. (2025). Cytisine Use Vs Nicotine Replacement Therapy in Relapsed Smokers with Heart Disease: Feasibility Results from a Pilot Randomized Trial. CJC Open, 8, 1062-1069. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40894854
Mohammad, A., Giakoumatos, C. I., Mekdessi, N. and Osser, D. N. (2025). A Review of Evidence and an Algorithm for Use of Psychopharmacology in the Treatment of Tobacco Use Disorder in Behavioral Health Settings. J Clin Psychopharmacol. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41025676
Prochaska, J., Rubinstein, M., Perdok, R., Blumenstein, B. and Jacobs, C. (2025). Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials. Thorax. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40962497
Ramos-Pinedo, A., de Granda-Orive, J. I., Cristobal-Fernandez, M. I., Rabade-Castedo, C., Perez-Fernandez, E., Vaquero-Lozano, P., Gorordo-Unzueta, M. I., Lazaro-Asegurado, L., de Higes-Martinez, E., Riesco-Miranda, J. A., Mirambeaux-Villalona, R., Francisco-Corral, G., Frino-Garcia, A., Minana, J. S., Villar-Laguna, C., Cicero-Guerrero, A. M., Vargas-Espinal, J. C., Pena-Miguel, T., Sellares, J. and Jimenez-Ruiz, C. A. (2025). Analysis of Effectiveness of Clinical Psychological Care Protocol for Smoking Cessation With Cytisinicline. Arch Bronconeumol. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40935698
Rigotti, N. A., Walker, N. and Amer Nordin, A. S. (2025). Integrating Pharmacotherapy into Tobacco Control in Low- and Middle-Income Countries - A Critical Need. N Engl J Med, 11, 1041-1044. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40948464
Shoenbill, K. A., Ostroff, J. S., Taylor, K. L., Jafarinia, A., Minion, M., Chichester, L. A., Omernik, B., McCall, M., Yeung, S., Wiseman, K., Chen, L. S., Salloum, R. G. and Warren, G. (2025). Recommendations for Standardization of Tobacco Use Treatment Data. J Thorac Oncol. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/41015336
Votaw, L., Hudmon, K. S., Shin, T. R. and Ablah, E. (2025). Stakeholder feedback regarding a statewide protocol for pharmacists to prescribe tobacco cessation medications. Explor Res Clin Soc Pharm, 100650. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40980187
El-Toukhy, S., Haghayegh, S., Leavens, E., Sassano, F. and Tarran, R. (2025). Use of non-invasive wearables biomonitoring to detect presmoking, smoking and postsmoking stages: protocol for an observational laboratory study. BMJ Open, 8, e103292. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40819863
Fraile-Martinez, O., Garcia-Montero, C., Ortega, M. A., Varaona, A., Gutierrez-Rojas, L., Alvarez-Mon, M. and Alvarez-Mon, M. A. (2025). Cytisinicline vs. Varenicline in Tobacco Addiction: A Literature Review Focused on Emotional Regulation, Psychological Symptoms, and Mental Health. Healthcare (Basel), 15. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40805814
La Rosa, G. R. M., Del Giovane, C., Minozzi, S., Kowalski, J., Chapple, I., Amaliya, A., Zakiawati, D., Ludovichetti, F. S., Kim, B. I., Tilakaratne, W. M., Farsalinos, K. and Polosa, R. (2025). Oral adverse event reporting in smoking cessation trials using non-combustible nicotine products: A quality assessment. J Dent, 106057. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40858203
Lafay-Chebassier, C., Girodet, P. O., Laine, F., Allain, J. S., Pickering, G., Latreille, M., Demina, A., Chevassus, H., Ingrand, I., Tartour, E., Benhamouda, N., Fraisse, M. L., Chamitava, L., Pletan, Y., Balland, J., Donazzolo, Y. and Lafont, B. (2025). Efficacy and Safety of NFL-101 as a Smoking Cessation Therapy: A Randomized Phase II Clinical Trial CESTO2. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40884488
Mogul, A. S., Laumann, K. N., Bautista, M., Fowler, J. P., Blough, B. E., Gay, E. A. and Fowler, C. D. (2025). Targeting GPR3 as a novel approach for nicotine cessation therapeutic development. Neuropsychopharmacology. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40866560
Singh, P. K., Tamrakar, V., Kapoor, S., Yadav, A. and Singh, S. (2025). Herbal tobacco cessation products on Indian e-commerce platforms: an emerging unregulated market with unsubstantiated health claims. Tob Control. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40803831
Veldhuizen, S., Yohannes, S., Tang, V., Selby, P. and Zawertailo, L. (2025). How soon should alternative smoking cessation treatments be offered after incomplete response to nicotine replacement therapy?. Drug Alcohol Depend, 112823. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40815911
Yang, M., Lohrmann, D. K., Huang, C., Jacobs, W. and Lin, H. C. (2025). Optimal Urinary Cotinine and Total Nicotine Equivalents (TNE-2) Cut-points for Distinguishing Tobacco Users from Non-Users among American Youth. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40795922
Yoshihara, S., Takahashi, K., Uemura, C., Murakami, S., Harada, D., Jiang, Y. and Yamato, H. (2025). Smoking Cessation Strategies for Different Types of Cigarette Users Using a Digital Peer-Supported App and Nicotine Aids: Prospective Study. J Med Internet Res, e75876. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40764052
Cioe, P. A., Stang, G. S., Azam, D. and Dugal, S. (2025). I've learned that I'm open-minded to this possibility: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke. Addict Sci Clin Pract, 1, 56. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40691651
Cooper, R. K., Gass, J., Mahoney, M. C., Tiffany, S. T., Colder, C. R., Maguin, E., Schlienz, N. J., Lawson, S. C., Tyndale, R. F., Sandhur, B. and Hawk, L. W. (2025). Do lab-based assessments of pretreatment smoking reinforcement and cue-specific craving predict smoking cessation with varenicline?. Psychol Addict Behav. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40720285
Cruvinel, E., Brown, A., Pritchard, A., Mayo, M. S., Cox, L. S., Leavens, E. L. S. and Nollen, N. L. (2025). Characteristics associated with medication adherence in a randomized clinical trial of multiple pharmacotherapy adaptations based on treatment response in black adults who smoke. Addict Behav, 108431. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40669292
D'Mello, K., Driezen, P., East, K. A., Fong, G. T. and Hammond, D. (2025). Trends in the use of vaping products and other smoking cessation methods among adults who attempt to stop smoking: Findings from ITC Four Country Smoking and Vaping Surveys (2016-2020). Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40709790
Glenn, D. L., Choi, S. H. and Zimmerman, R. S. (2025). A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction. J Psychopharmacol, 2.69881E+15. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40643107
Hitsman, B., D'Eletto, M., Gollan, J. K., Schnoll, R. A. and Papandonatos, G. D. (2025). Baseline predictors of smoking cessation among individuals with current or past major depressive disorder following treatment with varenicline and intensive behavioral treatment. Drug Alcohol Depend, 112761. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40582092
Keke, C., Lebina, L., Motlhaoleng, K., Niaura, R., Abrams, D., Variava, E., Gupte, N., Golub, J. E., Martinson, N. A. and Elf, J. L. (2025). The Nicotine Metabolite Ratio and Response to Smoking Cessation Treatment Among People Living with HIV Who Smoke in South Africa. Int J Environ Res Public Health, 7. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40724106
Yalla, B., Khanna, P., Sarkar, S., Lal, D., Maheshwari, A., Gupta, M. and Garg, B. (2025). Effect of perioperative transdermal nicotine patch on postoperative pain: A systematic review and meta-analysis. Indian J Anaesth, 7, 664-674. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40657138
Borelli, C., McGinity, M. and Gaub, M. (2025). Letter: Nicotine Replacement Therapy During the Spinal Surgery Perioperative Period. Neurosurgery. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40503904
Ikonomidis, I., Thymis, J., Kostelli, G., Katogiannis, K., Vlastos, D., Gatourtzidou, E. and Kourea, K. (2025). The effects of cytisinicline for smoking cessation on arterial stiffness, endothelial function, and myocardial performance: a pilot study. Eur Heart J Imaging Methods Pract, 1, qyaf062. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40469528
Pebley, K., J, D. N., Marshall, J. L. and Rojewski, A. M. (2025). Tobacco treatment billing and tobacco use disorder diagnosis in healthcare settings in the United States: an analysis of South Carolina medicaid claims. Subst Abuse Treat Prev Policy, 1, 24. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40514665
Hammad, A. M., Sunoqrot, S., Al-Zuhd, T., Waleed, M., Ibrahim, A. I. M., Hall, F. S., Al-Tamimi, A. R. and Al-Shalabi, E. (2025). Rhoifolin as a potential anxiolytic drug for the effects of nicotine withdrawal: beneficial effects on behavior, neuroinflammation, and oxidative stress. Metab Brain Dis, 5, 208. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40392377
Johnstone, S., Cooper, R. K., Wray, J. M., Tonkin, S., Knapp, K. S., Colder, C. R., Maguin, E., Mahoney, M. C., Tiffany, S. T., Brandon, T. H., Ashare, R. L. and Hawk, L. W. (2025). Sex-Specific Mediation of Pre-Quit Smoking Reduction: Secondary Analysis of a Randomized Controlled Trial Extending Varenicline Preloading. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40380787
Joyner, R. L., Phillips, R. E., Manshaii, F. A. and Davis, J. M. (2025). Use of low-dose varenicline in hospitalized smokers: A case series low-dose varenicline in hospitalized smokers. SAGE Open Med Case Rep, 2050313X251338637. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40343171
McKee, S. A. (2025). Is it time to update clinical care guidelines to address sex and gender differences in smoking cessation medication efficacy?. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40378250
Nasrun, M. W., Ginting, T. T., Siste, K., Pandelaki, J., Kekalih, A., Louisa, M., Susanto, A. D., Utami, D. S., Tarigan, I. N., Trishna, A. R. and Halim, K. (2025). Efficacy of N-acetylcysteine and motivational enhancement therapy for nicotine addiction: A randomized clinical trial. Narra J, 1, e2178. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40352229
Naughton, P., Sheridan, A. and Kavanagh, P. (2025). The impact of the introduction of universal access to free nicotine replacement therapy on the process and outcome of stop smoking services in Ireland. Public Health, 105758. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40347680
Patidar, N., Navale, A. M., Parsaila, N., Sharma, D., Nahar, P., Shinde, S., Solanki, N. and Shelke, A. (2025). Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway. Am J Transl Res, 4, 2396-2410. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40385053
Spangler, J., Skidmore, E., Dressler, E. V., Weaver, K. E., Lesser, G. J., Burton, G., Esparaz, B., Gillett, B. and Shaw, E. G. (2025). Randomized Placebo-Controlled Trial of Memantine for Smoking Cessation (CCCWFU 99311). Cancer Control, 1.07327E+16. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40340434
Tonkin, S. S., Betts, J. M., Dowd, A. N., Mahoney, M. C., Cinciripini, P. M., Schnoll, R. A., George, T. P., Tyndale, R. F. and Hawk, L. W., Jr. (2025). Daily cigarette abstinence and smoking rate with varenicline: Relationships with treatment, craving, and affect during the first week of the quit attempt. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40358028
Wang, Y. D., Wang, Y. T., Chen, H. H., Bao, J. K., Chen, S. M. and Chen, D. X. (2025). Pharmacovigilance Study on Adverse Events of Nicotine Replacement Therapy, Bupropion, and Varenicline in Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis, 1509-1524. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40391127
Huang, Y., Emery, J., McDaid, L., Naughton, F., Clark, M., Dickinson, A., Cooper, S. and Coleman, T. (2025). myCOtrak: an app which records smoking, nicotine use and exhaled carbon monoxide concentrations concurrently for use in smoking research. BMC Res Notes, 1, 158. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40211369
Martin, A., La Rosa, G. R. M., Rice, H., Bertuzzi, A., Witkowski, M., Anastasi, E., Geraci, G., Polosa, R. and DiaSmokeFree Working, G. (2025). Pharmacological interventions for smoking cessation in Type 2 diabetes: A systematic review with meta-analysis and GRADE evaluation. Diabetes Res Clin Pract, 112202. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40294654
Pei, Y., Gilliam, M., Listrom, O., Bermudez, A., Kenny, A., de Bruin, M., Noar, S. M., Goldstein, A. O. and Sheeran, P. (2025). Open science? Responsiveness to requests for data in a review of smoking cessation interventions. Ann Behav Med, 1. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40298095
Rigotti, N. A., Benowitz, N. L., Prochaska, J. J., Rubinstein, M., Clarke, A., Blumenstein, B., Cain, D. F. and Jacobs, C. (2025). Cytisinicline for Smoking Cessation: The ORCA Phase 3 Replication Randomized Clinical Trial. JAMA Intern Med. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40257755
Rose, J. E. (2025). Commentary on Johnstone et al.: Mechanisms underlying extended pre-quit varenicline treatment for smoking cessation. Addiction. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40194885
Beis, I., Dimou, A., Kotoulas, S. C. and Pataka, A. (2025). Nicotine replacement therapy as a smoking cessation tool for adolescents: an update. Front Psychiatry, 1525510. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40071276
Foxon, F. and Siegel, M. (2025). Scientific Inaccuracies in Smoking Cessation Guidance. Am J Med, 4, e64-e65. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40113376
Majo Garcia, R., Fernandez-Martinez, M. N., Crespo Sedano, A., Espinosa Villoria, M. G., Alonso Sastre, E. and Fernandez-Garcia, D. (2025). Effectiveness of Cytisinicline Treatment in Hospital Smoking Units. Open Respir Arch, 2, 100414. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40144923
Nichols, A. L., Marotta, C. B., Lukas, H. L., Friesenhahn, N. J., Wagenaar, D., Mayo, S. L., Dougherty, D. A., Benowitz, N., Gao, W., Muthusamy, A. K. and Lester, H. A. (2025). Continuous Nicotine Monitors for Personal Nicotine Pharmacokinetics: A Receptor-Aware Research Agenda. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40079271
Santiago-Torres, M., Westmaas, J. L., Ostroff, J. S., Mull, K. E., Sullivan, B. M., Unger, J. M. and Bricker, J. B. (2025). Overcoming challenges of recruiting cancer patients into clinical trials: insights from a randomized trial of app-based smoking cessation interventions. Am J Cancer Res, 2, 601-617. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40084371
Sheikhattari, P., Barsha, R. A. A., Egboluche, C., Foster, A. and Assari, S. (2025). CEASE Tobacco Cessation Program: Validation of Self-Rated Quit with Fagerstrom Test for Nicotine Dependence. Glob J Cardiovasc Dis, 1, 22-33. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40083628
Tesfaye, L., Wakeman, M., Gregory, T., Leahy, E., Baskin, G., Gruse, G., Kendrick, B. and El-Toukhy, S. (2025). Acceptability of a smart lighter for tracking cigarette smoking: A focus group study. Digit Health, 20552076251323998. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40151637
Tran, D. T., Cohen, J. M., Donald, S., Cesta, C. E., Furu, K., Parkin, L., Pearson, S. A., Reutfors, J., Robijn, A. L., Zoega, H., Zwar, N. and Havard, A. (2025). Risk of Major Congenital Malformations Following Prenatal Exposure to Smoking Cessation Medicines. JAMA Intern Med. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40163085
Urquhart, S. B., Webb, G. I., Leong, S. and Webb, A. R. (2025). The validity of self-reported smoking status on day of surgery in a mixed elective surgery population. Anaesth Intensive Care, 310057X251315764. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40148133
Whaley, R. C., Unger, J. B., Harlow, A. F., Barrington-Trimis, J. and Galimov, A. (2025). Blip World: nicotine replacement therapy for Gen Z?. Tob Control. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40157745
Yan, K., Xu, S., Fang, H., Yang, H. and Su, D. (2025). Next-generation immunotherapeutic strategy and clinical advances of vaccines against nicotine addiction. Vaccine, 127036. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40127570
Brito, M., Goncalves, A., Barros, A., Sousa, M. and Sa, R. (2025). Bupropion, the atypical antidepressant used in smoke cessation: an in vitro study on its effects on human sperm function. F S Sci. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/40015628
Chen, H., Luk, T. T., Guo, Z., Yip, A. O. N., Cheung, Y. T. D., Chan, S. S. C., Lam, T. H. and Wang, M. P. (2025). Real-World Effectiveness of Nicotine Replacement Therapy Sampling in Chinese Women of a Sex-Specific Smoking Cessation Program in Hong Kong, China. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39953958
Chen, K. L., Hsu, Y. C., Li, Y. H., Guo, F. R., Tsai, J. S., Cheng, S. Y. and Huang, H. L. (2025). Association of shared decision-making cessation model and adult smoking cessation rate: A prospective cohort study. Tob Induc Dis. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39897458
Egboluche, C., Barsha, R. A. A., Assari, S. and Sheikhattari, P. (2025). Clinical Trial Participation Motivation: Role of Smoking Status. Healthcare (Basel), 4. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39997264
Erika, T., Sofia, C., Alessandro, T., Laura, S., Lorenzo, L., Andrea, B., Rebecca, C., Silvia, M., Erica, S., Valeria, F., Elena, A., Paola, M., Fabio, L. and Cristiano, C. (2025). Cytisine for smoking cessation in hospitalised smokers with cardiovascular diseases: an observational study. Intern Emerg Med. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39939444
Johnstone, S., Cooper, R. K., Wray, J. M., Tonkin, S. S., Knapp, K. S., Colder, C. R., Maguin, E., Mahoney, M. C., Tiffany, S. T., Brandon, T. H., Ashare, R. L., Tyndale, R. F. and Hawk, L. W., Jr. (2025). Evaluating mediators of the effect of varenicline preloading on smoking abstinence in a randomized controlled trial. Addiction. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39915904
Kim, N., Kirsch, J., Millevolte, R., Oguss, M. K., Fraser, D. L., Kobinsky, K., Piper, M. E., Cook, J. W., Schlam, T. R., Baker, T. B., Fiore, M. C., Kathuria, H. and McCarthy, D. E. (2025). Representativeness of electronic referral to smoking treatment trials in adult primary care. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39985764
Kleinman, R. A. and Barnett, B. S. (2025). Eliminating the Medicare Coverage Gap for Intranasal Naloxone and Nicotine Replacement Therapy. JAMA. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39908047
Plum, C., Stolbrink, M., Ozoh, O., Jayasooriya, S., Nightingale, R., Mortimer, K. and Halpin, D. (2025). Availability, cost and affordability of essential medicines for smoking cessation in low-income and middle-income countries: a cross-sectional study. Thorax. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39900489
Rycroft, N., Kimber, C., Brazier, E. S. E. and Dawkins, L. (2025). Acute Effects of Nicotine on Non-Drug-Related Reward in Smokers and Non-Smokers. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39908407
Chuang, J., Lide, R. C., Kamath, N., Oliveto, A. and Addicott, M. (2025). A pilot study of ketamine among individuals with tobacco use disorder: tolerability and initial impact on tobacco use outcomes. J Addict Dis, 1-May. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39834135
Coley, K., Wang, Q., Packer, R., John, C., Abner, E., Reis, K., Estonian Biobank Research, T., Bedair, K. F., Srinivasan, S., Paciga, S., Hyde, C., Free, R. C., Reeve, N. F., Shepherd, D. J., Esko, T., Palmer, C., Pearson, E., Malarstig, A., Tobin, M. D. and Batini, C. (2025). Genome-wide association study of varenicline-aided smoking cessation. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39792440
Fakih, T. M., Rizkita, A. D., Dewi, S. A. and Muchtaridi, M. (2025). In silico approaches for developing sesquiterpene derivatives as antagonists of human nicotinic acetylcholine receptors (nAChRs) for nicotine addiction treatment. Curr Res Struct Biol, 100162. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39867106
Jackson, S. E., Brown, J., Buss, V. and Shahab, L. (2025). Prevalence of Popular Smoking Cessation Aids in England and Associations With Quit Success. JAMA Netw Open, 1, e2454962. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39821398
Kochhar, S., Scholten, H., Maciejewski, D. F., Pingel, M. A. and Luijten, M. (2025). A mixed-methods investigation of an ecological momentary assessment protocol for cigarette-smoking youth: Psychometric properties and participant experiences. Drug Alcohol Depend Rep, 100314. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39867465
Mir, H., Heshmati, J., Mullen, K. A., Baldwin, A., Quirouette, E., Pipe, A. and Reid, R. (2025). Cytisine compared to combination nicotine replacement therapy to reduce cigarette consumption in relapsed smokers: protocol for a pilot randomized controlled trial. Pilot Feasibility Stud, 1, 10. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39876021
Ruiz-Salcedo, S., Ranchal-Sanchez, A., Ruiz-Moruno, J., Montserrat-Villatoro, J., Jurado-Castro, J. M. and Romero-Rodriguez, E. (2024). Multicentre Pilot Study to Evaluate the Efficacy of Targeted Exercise in Combination with Cytisinicline on Smoking Cessation at 12 Months: MEDSEC-CTA. Healthcare (Basel), 24. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39765943
Santiago-Torres, M., Mull, K. E., Sullivan, B. M., Cupertino, A. P., Salloum, R. G., Triplette, M., Zvolensky, M. J. and Bricker, J. B. (2025). Evaluating the Impact of Pharmacotherapy in Augmenting Quit Rates Among Hispanic Adults in an App-Delivered Smoking Cessation Intervention: Secondary Analysis of a Randomized Controlled Trial. JMIR Form Res, e69311. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39889280
Schell, C., Godinho, A., Chaiton, M., Leatherdale, S. T. and Cunningham, J. A. (2025). Targeted distribution of nicotine patches by mail to rural regions of Canada: Predictors of patch use. Tob Prev Cessat. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39867464
Sonmez, T. G. and Fidanci, I. (2024). Cytisine as an Emerging Tool for Smoking Cessation and Addiction Treatment. Iran J Public Health, 12, 2823-2824. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39759201
Theodoulou, A., Fanshawe, T. R., Leavens, E., Theodoulou, E., Wu, A. D., Heath, L., Stewart, C., Nollen, N., Ahluwalia, J. S., Butler, A. R., Hajizadeh, A., Thomas, J., Lindson, N. and Hartmann-Boyce, J. (2025). Differences in the effectiveness of individual-level smoking cessation interventions by socioeconomic status. Cochrane Database Syst Rev, 1, CD015120. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39868569
Yammine, L., de Dios, C., Suchting, R., Green, C. E., Nielsen, D. A., Walss-Bass, C. and Schmitz, J. M. (2025). Exploring Predictors of Treatment Response to GLP-1 Receptor Agonists for Smoking Cessation. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39780397
Abdelwahab, N., Allen, A., Harrison, K., Petersen, A. and Allen, S. (2024). A protocol for modifying progesterone to increase postpartum cigarette smoking abstinence and reduce secondhand smoke exposure in infants. Contemp Clin Trials Commun, 101389. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39618477
Coffee, Z., Hsu, C. H., Vanderah, T. W. and Gordon, J. S. (2024). Predictors of Enrollment and Adherence in a Randomized Tobacco Cessation Clinical Trial. Tob Use Insights, 1179173X241308136. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39678308
Cohen, G., Bellanca, C. M., Bernardini, R., Rose, J. E. and Polosa, R. (2024). Personalized and adaptive interventions for smoking cessation: Emerging trends and determinants of efficacy. iScience, 11, 111090. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39620129
Maheshwari, A., Gupta, M., Garg, B., Singh, A. K. and Khanna, P. (2024). Effect of Nicotine Replacement Therapy on Perioperative Pain Management and Opioid Requirement in Abstinent Tobacco Smokers Undergoing Spinal Fusion: A Double-blind Randomized Controlled Trial. J Neurosurg Anesthesiol. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39719676
Selbach, C., Siebel, C., Lilienthal, J., Grouven, U., Knelangen, M., Kastaun, S. and Kranz, P. (2025). Weaning From Tobacco with Nicotine or Varenicline in Severe and Mild Tobacco Dependence-Findings of a Meta-Analysis. Dtsch Arztebl Int, Forthcoming. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39628402
Wolf, B. J., Gray, K. M., Dahne, J. R., Hashemi, D. and Tomko, R. L. (2024). Can We Predict Who Will Experience Adverse Events While Using Smoking Cessation Pharmacotherapy? A Secondary Analysis of the EAGLES Clinical Trial. Nicotine Tob Res. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39658081
Xing, C., Malaty, J., Malham, M. B., Orlando, F. A., Lynch, A., Huo, Z., Francois, M., Firpi-Morell, R., Fisher, C. L., Christou, D. D. and Salloum, R. G. (2024). The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and insomnia: study protocol for a randomized clinical trial. BMC Complement Med Ther, 1, 422. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/39709468